Targeting Human Dendritic Cells via DEC-205 Using PLGA Nanoparticles Leads to Enhanced Cross-Presentation of a Melanoma-Associated Antigen

International Journal of Nanomedicine- New Zealand

doi 10.2147/ijn.s66639

Full Text

Abstract

Available in

Categories

Organic Chemistry

Pharmaceutical Science

Date

November 1, 2014

Authors

Robert Tigelaar

Richard Edelson

Publisher

Informa UK Limited

Related search

Recruitment of Rab27a to Phagosomes Controls Microbial Antigen Cross-Presentation by Dendritic Cells

Infection and Immunity

Infectious Diseases

English

Tumor Cells, Rather Than Dendritic Cells, Deliver Antigen to the Lymph Node for Cross-Presentation

English

Correction: Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

Journal of Immunology

English

Chimeric Antigen Receptor Engineered Human Gamma Delta T Cells; Enhanced Cytotoxicity With Retention of Cross Presentation

Molecular Therapy

Molecular Medicine

Molecular Biology

English

ICAM-1 Targeting of Doxorubicin-Loaded PLGA Nanoparticles to Lung Epithelial Cells

European Journal of Pharmaceutical Sciences

Pharmaceutical Science

English

Targeting Dendritic Cells With Antigen-Containing Liposomes

Cancer Research

Cancer Research

English

TLR-dependent Phagosome Tubulation in Dendritic Cells Promotes Phagosome Cross-Talk to Optimize MHC-II Antigen Presentation

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation

Frontiers in Immunology

English

Extracellular Antigen Processing and Presentation by Immature Dendritic Cells

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English